[68Ga]Ga-OncoACP3 for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Sep 2026: Trial registered, NCT07830212
  2. 10 Oct 2026: Trial started, NCT07830212

The trials

NCT07830212: Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study

State
Under way
Phase
Phase 2
People
50 planned
Started
10 Oct 2026
Primary completion
Jun 2028
Arms
[68Ga]Ga-OncoACP3 PET Imaging
Results
None posted
  1. 21 Sep 2026: Trial registered
  2. 10 Oct 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.